L089-1315 Screening compound: N-[(E)-N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]-3,5-dimethoxybenzamide

L089-1315 Screening compound: N-[(E)-N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]-3,5-dimethoxybenzamide
L089-1315 Screening compound: N-[(E)-N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]-3,5-dimethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L089-1315
N-[(E)-N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]-3,5-dimethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L089-1315

Molecular Formula

C24H30N4O6 (C24 H30 N4 O6)

Compound Name

N-[(E)-N'-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]-3,5-dimethoxybenzamide

IUPAC name

N-[(E)-N'-(23-dihydro-14-benzodioxin-6-yl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]-35-dimethoxybenzamide

SMILES

COc1cc(C(N/C(/NCCN2CCOCC2)=N/c(cc2)cc3c2OCCO3)=O)cc(OC)c1

InChI

InChI=1S/C24H30N4O6/c1-30-19-13-17(14-20(16-19)31-2)23(29)27-24(25-5-6-28-7-9-32-10-8-28)26-18-3-4-21-22(15-18)34-12-11-33-21/h3-4,13-16H,5-12H2,1-2H3,(H2,25,26,27,29)

InChI Key

INYALZZLJFAYOX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27231659

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.53

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.757

Distribution Coefficient, logD

0.612

Water Solubility, LogSw

-2.26

Polar Surface Area

84.495

Acid Dissociation Constant (pKa)

12.26

Base Dissociation Constant (pKb)

8.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

L089-1315 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases
Agro:
  • Agro

References: we are preparing a list of scientific research reports with L089-1315 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L089-1315?
Check Price and Availability of L089-1315, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L089-1315 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L089-1315
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L089-1315
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L089-1315 available by request